Clinical Trial

ATR 1072 in Participants With PRKAG2 Syndrome

Name: ATR 1072 in Participants With PRKAG2 Syndrome — clinical trial record (NCT07738107)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

ATR 1072 is an investigational medicine being studied in adults with PRKAG2 Syndrome. This study will evaluate the safety of ATR 1072 and how the body processes the drug. Researchers will also assess how ATR 1072 affects PRKAG2 activity and measures of heart disease.

Trial Details

NCT Number	NCT07738107
Lead Sponsor	Atrium Therapeutics
Conditions	Cardiac Glycogenosis, Cardiomyopathy, Hypertrophic, Wolff-Parkinson-White Syndrome
Enrollment	37 participants
Start Date	2026-10
Primary Completion	2028-05 (estimated)
Study Completion	2028-10 (estimated)
Updated on ClinicalTrials.gov	2026-07-31